An empirical process for the design of high-throughput screening deck filters

被引:77
作者
Pearce, Bradley C.
Sofia, Michael J.
Good, Andrew C.
Drexler, Dieter M.
Stock, David A.
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, New Leads Cheminformat Appl Biotechnol, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Comp Assisted Drug Design Appl Biotechnol, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Analyt Sci Pharmaceut Candidate Optimiz, Wallingford, CT 06492 USA
[4] Bristol Myers Squibb Co, Pharmaceut Res Inst, NonClin Biostat, Wallingford, CT 06492 USA
关键词
D O I
10.1021/ci050504m
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A process for objective identification and filtering of undesirable compounds that contribute to high-throughput screening (HTS) deck promiscuity is described. Two methods of mapping hit promiscuity have been developed linking SMARTS-based structural queries with historical primary HTS data. The first compares an expected assay hit rate to actual hit rates. The second examines the propensity of an individual compound to hit multiple assays. Statistical evaluation of the data indicates a correlation between the resultant functional group filters and compound promiscuity. These data corroborate a number of commonly applied filters as well as producing some unexpected results. Application of these models to HTS collection triage reduced the number of in-house compounds considered for screening by 12%. The implications of these findings are further discussed in the context of the HTS screening set and combinatorial library design as well as compound acquisition.
引用
收藏
页码:1060 / 1068
页数:9
相关论文
共 44 条
[1]  
*ACS, 2005, 229 AM CHEM SOC NAT
[2]  
[Anonymous], 1970, Introductory Probability and Statistical Applications
[3]   Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds [J].
Baurin, N ;
Baker, R ;
Richardson, C ;
Chen, I ;
Foloppe, N ;
Potter, A ;
Jordan, A ;
Roughley, S ;
Parratt, M ;
Greaney, P ;
Morley, D ;
Hubbard, RE .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (02) :643-651
[4]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[5]  
Blower Paul E Jr, 2004, Curr Drug Discov Technol, V1, P37, DOI 10.2174/1570163043484879
[6]  
BUKO AM, 2001, STABILITY TESTING CH
[7]   Filtering databases and chemical libraries [J].
Charifson, PS ;
Walters, WP .
MOLECULAR DIVERSITY, 2000, 5 (04) :185-197
[8]   Studies on repository compound stability in DMSO under various conditions [J].
Cheng, XH ;
Hochlowski, J ;
Tang, H ;
Hepp, D ;
Beckner, C ;
Kantor, S ;
Schmitt, R .
JOURNAL OF BIOMOLECULAR SCREENING, 2003, 8 (03) :292-304
[9]   Deriving knowledge through data mining high-throughput screening data [J].
Diller, DJ ;
Hobbs, DW .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (25) :6373-6383
[10]  
DOMAN TN, 2004, IDENTIFICATION PREDI